Integra LifeSciences Holdings (IART)

Current ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total current assets US$ in thousands 1,081,680 1,099,520 1,112,290 1,415,650 1,058,040 1,027,230 1,051,260 1,029,480 1,161,500 1,196,450 1,137,410 1,066,050 1,153,720 1,103,780 1,032,380 1,039,080 1,237,200 1,152,100 966,222 1,008,670
Total current liabilities US$ in thousands 922,126 912,563 328,316 302,394 306,980 355,712 377,496 282,293 320,906 304,452 295,596 315,833 340,021 332,858 318,756 412,301 401,013 255,146 212,415 246,485
Current ratio 1.17 1.20 3.39 4.68 3.45 2.89 2.78 3.65 3.62 3.93 3.85 3.38 3.39 3.32 3.24 2.52 3.09 4.52 4.55 4.09

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $1,081,680K ÷ $922,126K
= 1.17

Integra LifeSciences Holdings has shown fluctuating current ratios over the past few years. The current ratio measures a company's ability to cover its short-term obligations with its current assets.

The company's current ratio has generally been above 3, which indicates a healthy level of liquidity. A current ratio of 3 means that Integra LifeSciences Holdings has $3 in current assets for every $1 in current liabilities.

Over the last few quarters, the current ratio has ranged from a high of 4.68 to a low of 1.17. The highest current ratio of 4.68 on March 31, 2024, suggests that the company had ample current assets to cover its short-term liabilities at that time.

However, the downward trend in the current ratio since then, dropping to 1.17 on December 31, 2024, raises some concerns about the company's liquidity position. A current ratio below 1 would indicate that the company may have difficulty meeting its short-term obligations.

It would be important for stakeholders to monitor Integra LifeSciences Holdings' current ratio closely in future periods to ensure the company maintains an appropriate level of liquidity to meet its short-term financial obligations.